Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-month open-label pregabalin adjunctive safety study in seizures
2011-001412-65Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in Focal onset seizure and generalized tonic-clonic seizure (GTCS), sponsored by Pfizer. Primary endpoint: Adverse events. Started Dec 2011; status: completed.
02
Drugs
pregabalin
03
Conditions
Focal onset seizuregeneralized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on 2011-001412-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001412-65.